ATE298256T1 - Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung - Google Patents

Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung

Info

Publication number
ATE298256T1
ATE298256T1 AT01959403T AT01959403T ATE298256T1 AT E298256 T1 ATE298256 T1 AT E298256T1 AT 01959403 T AT01959403 T AT 01959403T AT 01959403 T AT01959403 T AT 01959403T AT E298256 T1 ATE298256 T1 AT E298256T1
Authority
AT
Austria
Prior art keywords
hyaluronic acid
microspheres
utility
properties
tissues
Prior art date
Application number
AT01959403T
Other languages
English (en)
Inventor
Ronald K Yamamoto
Stanley R Conston
Original Assignee
Iscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iscience Corp filed Critical Iscience Corp
Application granted granted Critical
Publication of ATE298256T1 publication Critical patent/ATE298256T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01959403T 2000-07-31 2001-07-31 Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung ATE298256T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62900000A 2000-07-31 2000-07-31
PCT/US2001/024149 WO2002009787A1 (en) 2000-07-31 2001-07-31 Microparticulate biomaterial composition for medical use

Publications (1)

Publication Number Publication Date
ATE298256T1 true ATE298256T1 (de) 2005-07-15

Family

ID=24521177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01959403T ATE298256T1 (de) 2000-07-31 2001-07-31 Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung

Country Status (8)

Country Link
EP (1) EP1305057B1 (de)
JP (1) JP2004505065A (de)
AT (1) ATE298256T1 (de)
DE (1) DE60111637T2 (de)
DK (1) DK1305057T3 (de)
ES (1) ES2244641T3 (de)
PT (1) PT1305057E (de)
WO (1) WO2002009787A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
SE0401182D0 (sv) * 2004-05-05 2004-05-05 Q Med Ab Novel use of a viscoelastic composition
US7956180B2 (en) 2004-05-27 2011-06-07 Novozymes A/S Dried and agglomerated hyaluronic acid product
CA2567722C (en) * 2004-05-27 2013-06-18 Novozymes Biopolymer A/S A dried and agglomerated hyaluronic acid product
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US9157054B2 (en) 2007-11-14 2015-10-13 The University Of Queensland Device and method for preparing microparticles
ITFI20130074A1 (it) * 2013-04-03 2014-10-04 Ambrosone Orazio Soluzione acquosa di contrasto per rendere visibile mediante metodica fotografica il canale di schlemm e le vie di deflusso dell¿umore acqueo e metodo diagnostico che utilizza detta soluzione.
EP3600441A1 (de) 2017-03-22 2020-02-05 Genentech, Inc. Hydrogelvernetzte hyaluronsäure-prodrug-zusammensetzungen und verfahren
CN114796619B (zh) * 2022-04-14 2023-03-14 珠海麦得发生物科技股份有限公司 可注射透明质酸微球及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733426B1 (fr) * 1995-04-25 1997-07-18 Debacker Yves Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique
US5752974A (en) * 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
FR2759576B1 (fr) * 1997-02-17 1999-08-06 Corneal Ind Implant de sclero-keratectomie pre-descemetique
AU9313298A (en) * 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
IT1302534B1 (it) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per

Also Published As

Publication number Publication date
JP2004505065A (ja) 2004-02-19
DE60111637D1 (de) 2005-07-28
ES2244641T3 (es) 2005-12-16
PT1305057E (pt) 2005-11-30
DE60111637T2 (de) 2006-05-11
DK1305057T3 (da) 2005-10-24
WO2002009787A1 (en) 2002-02-07
EP1305057A1 (de) 2003-05-02
EP1305057B1 (de) 2005-06-22

Similar Documents

Publication Publication Date Title
US9468779B2 (en) Viscoelastic gel for dermatological use
KR102277655B1 (ko) 분말 형태로 첨가되는 리도카인 및 알칼리 제제를 포함하며 히알루론산을 기본 성분으로 하고 열에 의해 살균된, 주입가능한 하이드로겔의 수득 방법
GEP20022804B (en) Erythropoietin Derivatives
ES2155043B1 (es) Composiciones farmaceuticas comprendiendo acido pirimidin-5-il(3r, 5s)-3,5-dihidroxihept-6-enoico o una sal suya, su estabilizacion con sal fosfato tribasico y su preparacion.
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ATE424848T1 (de) Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen
DE60316291D1 (de) Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung
ATE298256T1 (de) Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung
DE602004005564T2 (de) Pharmazeutische Zusammensetzung für Thrombinpeptidderivaten
EP0138216A2 (de) IFN-Präparat mit verzögerter Abgabe für parentale Verabreichung
WO2001038303A3 (fr) Analogues de la vitamine d
ATE220917T1 (de) Monodisperse formulierungen, die hexamere acylierte insulinanaloge enthalten
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
WO2017131130A1 (ja) コンドロイチン硫酸及びヒアルロン酸を含有する安定化された水性組成物
ATE424192T1 (de) Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
CA2455776C (en) Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field
BR0015770A (pt) Compostos bicìclicos análogos de vitamina d, uso de um composto, composição farmacêutica, composição cosmética e uso de uma composição cosmética
AP1919A (en) Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same
Taguchi et al. Evaluation of tumor tissue fixation effects of formulation modified Mohs pastes in mice and their water-absorbing properties
DE69736985D1 (de) Biologisch aktive zusammensetzung
JP6656890B2 (ja) フィラグリン産生促進剤
DE60112584D1 (de) Verfahren zur Herstellung einer flüssigen Dosierungseinheit und Kit
RU2204386C2 (ru) Композиция для новообразования коллагена
JP2018193329A (ja) トランスグルタミナーゼ発現促進剤

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1305057

Country of ref document: EP

REN Ceased due to non-payment of the annual fee